192 related articles for article (PubMed ID: 25301490)
1. Orbital radiotherapy in the management of Graves' orbitopathy--current state of knowledge.
Ruchała M; Hernik A; Zybek A
Endokrynol Pol; 2014; 65(5):388-96. PubMed ID: 25301490
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of orbital radiotherapy for graves' orbitopathy.
Tanda ML; Bartalena L
J Clin Endocrinol Metab; 2012 Nov; 97(11):3857-65. PubMed ID: 22962421
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
Marcocci C; Marinò M
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):325-37. PubMed ID: 22632369
[TBL] [Abstract][Full Text] [Related]
5. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
[TBL] [Abstract][Full Text] [Related]
7. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
Bartalena L
Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy of Intravenous Steroids and Orbital Irradiation is More Effective Than Intravenous Steroids Alone in Patients with Graves' Orbitopathy.
Oeverhaus M; Witteler T; Lax H; Esser J; Führer D; Eckstein A
Horm Metab Res; 2017 Oct; 49(10):739-747. PubMed ID: 28922676
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves' orbitopathy.
Sterker I; Tegetmeyer H; Papsdorf K; Führer-Sakel D
Horm Metab Res; 2009 May; 41(5):391-6. PubMed ID: 19194836
[TBL] [Abstract][Full Text] [Related]
10. [Graves' orbitopathy].
Eckstein A; Möller L; Führer D; Oeverhaus M
Dtsch Med Wochenschr; 2021 Oct; 146(20):1344-1351. PubMed ID: 34644795
[TBL] [Abstract][Full Text] [Related]
11. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
12. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
[TBL] [Abstract][Full Text] [Related]
13. A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2020 Apr; 127(4S):S160-S171. PubMed ID: 32200817
[TBL] [Abstract][Full Text] [Related]
14. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for Graves' orbitopathy.
Marcocci C; Altea MA; Leo M
Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of radiation therapy in the treatment of Graves' orbitopathy.
Matthiesen C; Thompson JS; Thompson D; Farris B; Wilkes B; Ahmad S; Herman T; Bogardus C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):117-23. PubMed ID: 21030157
[TBL] [Abstract][Full Text] [Related]
17. Graves orbitopathy: update on diagnosis and therapy.
Melcescu E; Horton WB; Kim D; Vijayakumar V; Corbett JJ; Crowder KW; Pitman KT; Uwaifo GI; Koch CA
South Med J; 2014 Jan; 107(1):34-43. PubMed ID: 24389785
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy for Graves' ophthalmopathy].
Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
[TBL] [Abstract][Full Text] [Related]
19. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy.
Kulig G; Andrysiak-Mamos E; Sowińska-Przepiera E; Kulig J; Karakiewicz B; Brodowski J; Robaczyk M; Homa K; Letkiewicz M; Syrenicz A
Endokrynol Pol; 2009; 60(3):158-65. PubMed ID: 19569015
[TBL] [Abstract][Full Text] [Related]
20. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
Juri J; Stiglmayer N; Kuzman T
Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
